Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
Authors
Keywords
-
Journal
Cellular & Molecular Immunology
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-02-18
DOI
10.1038/s41423-019-0206-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetics of Natural Killer Cells in Human Health, Disease, and Survival
- (2018) Peter Parham et al. Annual Review of Immunology
- Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
- (2018) Frank Vari et al. BLOOD
- NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines
- (2018) Leticía Huergo-Zapico et al. CANCER RESEARCH
- Chemokine regulation of innate lymphoid cell tissue distribution and function
- (2018) Alessandra Soriani et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
- (2018) Quirin Hammer et al. NATURE IMMUNOLOGY
- PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
- (2018) Michael R. Migden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activating and inhibitory receptors expressed on innate lymphoid cells
- (2018) Sophie Guia et al. Seminars in Immunopathology
- NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia
- (2018) Franco Locatelli et al. TRENDS IN IMMUNOLOGY
- Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells
- (2018) Felix S. Lichtenegger et al. Frontiers in Immunology
- Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias
- (2018) Vito Pistoia et al. Frontiers in Immunology
- Late Development of FcεRγneg Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation Recipients
- (2018) Letizia Muccio et al. Frontiers in Immunology
- TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
- (2018) Alice L. Hung et al. OncoImmunology
- Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor
- (2018) Silvia Gaggero et al. OncoImmunology
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
- (2018) Joy Hsu et al. JOURNAL OF CLINICAL INVESTIGATION
- Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells
- (2018) Linda Quatrini et al. NATURE IMMUNOLOGY
- Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
- (2018) Nayoung Kim et al. Frontiers in Immunology
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8+ T Cells
- (2018) Xiu-Man Zhou et al. Frontiers in Immunology
- Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency
- (2017) Yannick Simoni et al. IMMUNITY
- Tim-3 and its role in regulating anti-tumor immunity
- (2017) Madhumita Das et al. IMMUNOLOGICAL REVIEWS
- TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
- (2017) William C. Dougall et al. IMMUNOLOGICAL REVIEWS
- Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells
- (2017) Maria Carmen Ochoa et al. IMMUNOLOGY AND CELL BIOLOGY
- Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
- (2017) Silvia Pesce et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer
- (2017) Reinhard Büttner et al. JOURNAL OF CLINICAL ONCOLOGY
- IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity
- (2017) Martina Molgora et al. NATURE
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more
- (2017) Laura Chiossone et al. SEMINARS IN IMMUNOLOGY
- PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability
- (2017) Enrico Munari et al. Oncotarget
- Regulation of the Functions of Natural Cytotoxicity Receptors by Interactions with Diverse Ligands and Alterations in Splice Variant Expression
- (2017) Tatiana Pazina et al. Frontiers in Immunology
- KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing
- (2017) Simona Carlomagno et al. Frontiers in Immunology
- The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF
- (2016) Francesca Moretta et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Human innate lymphoid cells
- (2016) Elisa Montaldo et al. IMMUNOLOGY LETTERS
- NK Cells Restrain Spontaneous Antitumor CD8+T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells
- (2016) Ximena L. Raffo Iraolagoitia et al. JOURNAL OF IMMUNOLOGY
- The evolution of innate lymphoid cells
- (2016) Eric Vivier et al. NATURE IMMUNOLOGY
- Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1
- (2016) Wilfredo F Garcia-Beltran et al. NATURE IMMUNOLOGY
- PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
- (2016) Asma Beldi-Ferchiou et al. Oncotarget
- Features of Memory-Like and PD-1+ Human NK Cell Subsets
- (2016) Mariella Della Chiesa et al. Frontiers in Immunology
- The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells
- (2016) Sonja Textor et al. OncoImmunology
- Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer
- (2016) Gulidanna Shayan et al. OncoImmunology
- HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1
- (2016) Aura Burian et al. PLoS One
- Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias
- (2015) Gabriella Pietra et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing +T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies
- (2015) L. Muccio et al. HAEMATOLOGICA
- Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma
- (2015) Liyun Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The biology of innate lymphoid cells
- (2015) David Artis et al. NATURE
- NCR+ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures
- (2015) Paolo Carrega et al. Nature Communications
- Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing +T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies
- (2015) L. Muccio et al. HAEMATOLOGICA
- NKG2D Receptor and Its Ligands in Host Defense
- (2015) L. L. Lanier Cancer Immunology Research
- Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?
- (2015) Mariella Della Chiesa et al. Frontiers in Immunology
- B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape
- (2015) Silvia Pesce et al. OncoImmunology
- Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell-Activating Receptor NKp30
- (2014) E. Schlecker et al. CANCER RESEARCH
- Effect of tumor cells and tumor microenvironment on NK-cell function
- (2014) Massimo Vitale et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Human RORγt+CD34+ Cells Are Lineage-Specified Progenitors of Group 3 RORγt+ Innate Lymphoid Cells
- (2014) Elisa Montaldo et al. IMMUNITY
- CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
- (2014) Yu-Hwa Huang et al. NATURE
- IL-25-responsive, lineage-negative KLRG1hi cells are multipotential ‘inflammatory’ type 2 innate lymphoid cells
- (2014) Yuefeng Huang et al. NATURE IMMUNOLOGY
- Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
- (2014) I. P. da Silva et al. Cancer Immunology Research
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions
- (2013) J. Matta et al. BLOOD
- Identification of a cellular ligand for the natural cytotoxicity receptor NKp44
- (2013) F. Baychelier et al. BLOOD
- Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity
- (2013) K. S. Reiners et al. BLOOD
- Polymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer Cells
- (2013) Susan L. Heatley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
- (2013) Maryam Salimi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
- (2013) Taku Okazaki et al. NATURE IMMUNOLOGY
- Location and cellular stages of natural killer cell development
- (2013) Jianhua Yu et al. TRENDS IN IMMUNOLOGY
- Signatures of Human NK Cell Development and Terminal Differentiation
- (2013) Merlin Luetke-Eversloh et al. Frontiers in Immunology
- Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor
- (2012) Mirna Balsamo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
- (2012) Xin Gao et al. PLoS One
- KIR2DL4 (CD158d): An activation receptor for HLA-G
- (2012) Sumati Rajagopalan et al. Frontiers in Immunology
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Proliferating Cell Nuclear Antigen Is a Novel Inhibitory Ligand for the Natural Cytotoxicity Receptor NKp44
- (2011) B. Rosental et al. JOURNAL OF IMMUNOLOGY
- Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection
- (2011) S. Lopez-Verges et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells
- (2011) P. Vacca et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Origin, phenotype and function of human natural killer cells in pregnancy
- (2011) Paola Vacca et al. TRENDS IN IMMUNOLOGY
- Dissecting CD56dim human NK cells
- (2010) L. Moretta BLOOD
- A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2
- (2010) S. Sivori et al. BLOOD
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic Cells
- (2010) Rosemarie H. DeKruyff et al. JOURNAL OF IMMUNOLOGY
- KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C
- (2009) Thorsten Graef et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model
- (2009) N. T. Joncker et al. JOURNAL OF IMMUNOLOGY
- Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
- (2008) D. Pende et al. BLOOD
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now